Basics Verona Pharma Verona Pharma PLC develops drugs for respiratory diseases. Its products mainly include anti-inflammatory agents and bronchodilators. IPO Date: April 24, 2017 Sector: Healthcare Industry: Biotech Market Cap: $9.2B Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 2.79% Avg Daily Range (30 D): $0.13 | 0.12% Avg Daily Range (90 D): $0.92 | 1.16% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): 1.57M Avg Daily Volume (90 D): 2.78M Trade Size Avg Trade Size (Sh.): 107 Avg Trade Size (Sh.) (30 D): 134 Avg Trade Size (Sh.) (90 D): 138 Institutional Trades Total Inst.Trades: 2,256 Avg Inst. Trade: $3.26M Avg Inst. Trade (30 D): $6.96M Avg Inst. Trade (90 D): $5.46M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 4 Market Closing Trades Avg Closing Trade: $2.76M Avg Closing Trade (30 D): $5.88M Avg Closing Trade (90 D): $5.27M Avg Closing Volume: 52.05K     News Sep 3, 2025 @ 5:00 PM PDE4B Inhibitor Market Poised for Strong Growth by... Source: Delveinsight Aug 5, 2025 @ 5:00 PM Global Chronic Obstructive Pulmonary Disease Treat... Source: Delveinsight Jul 29, 2025 @ 3:19 PM Merck Q2: EPS Beats, but Sales Flat as Vaccine Dem... Source: Timothy Fries Jul 19, 2025 @ 2:43 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: Halper Sadeh Llc Jul 17, 2025 @ 12:15 PM Merck Just Announced a $10 Billion Deal That Will ... Source: David Jagielski Financials   TTM Q2 2025 Q1 2025 Basic EPS $.02 $-.02 Diluted EPS $.02 $-.02 Revenue $ $ 103.14M $ 76.26M Gross Profit $ $ $ Net Income / Loss $ $ 11.92M $ -16.32M Operating Income / Loss $ $ 13.31M $ -10.32M Cost of Revenue $ $ $ Net Cash Flow $ $ 36.6M $ 1.66M PE Ratio